BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38154440)

  • 21. p73 protein expression correlates with radiation-induced apoptosis in the lack of p53 response to radiation therapy for cervical cancer.
    Wakatsuki M; Ohno T; Iwakawa M; Ishikawa H; Noda S; Ohta T; Kato S; Tsujii H; Imai T; Nakano T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1189-94. PubMed ID: 18313527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T0070907, a PPAR γ inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe.
    An Z; Muthusami S; Yu JR; Park WY
    Reprod Sci; 2014 Nov; 21(11):1352-61. PubMed ID: 24642720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo.
    Liu Y; Cui B; Qiao Y; Zhang Y; Tian Y; Jiang J; Ma D; Kong B
    Int J Gynecol Cancer; 2011 Jan; 21(1):100-5. PubMed ID: 21330835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer and radiosensitizing effects of the cyclin-dependent kinase inhibitors, AT7519 and SNS‑032, on cervical cancer.
    Kang MA; Kim W; Jo HR; Shin YJ; Kim MH; Jeong JH
    Int J Oncol; 2018 Aug; 53(2):703-712. PubMed ID: 29901072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganetespib radiosensitization for liver cancer therapy.
    Chettiar ST; Malek R; Annadanam A; Nugent KM; Kato Y; Wang H; Cades JA; Taparra K; Belcaid Z; Ballew M; Manmiller S; Proia D; Lim M; Anders RA; Herman JM; Tran PT
    Cancer Biol Ther; 2016 Apr; 17(4):457-66. PubMed ID: 26980196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation.
    Milrot E; Jackman A; Flescher E; Gonen P; Kelson I; Keisari Y; Sherman L
    Invest New Drugs; 2013 Apr; 31(2):333-44. PubMed ID: 22956285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selenium in oncology: from chemistry to clinics.
    Micke O; Schomburg L; Buentzel J; Kisters K; Muecke R
    Molecules; 2009 Oct; 14(10):3975-88. PubMed ID: 19924043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiated thyroid cancer and selenium supplements for protection of salivary glands from
    Mazokopakis E
    Hell J Nucl Med; 2018; 21(1):83-84. PubMed ID: 29550852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of selenium nanoparticles, characterization and X-ray induced radiotherapy for the treatment of lung cancer with interstitial lung disease.
    Cruz LY; Wang D; Liu J
    J Photochem Photobiol B; 2019 Feb; 191():123-127. PubMed ID: 30616036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionalized Selenium Nanosystem as Radiation Sensitizer of
    Yang Y; Xie Q; Zhao Z; He L; Chan L; Liu Y; Chen Y; Bai M; Pan T; Qu Y; Ling L; Chen T
    ACS Appl Mater Interfaces; 2017 Aug; 9(31):25857-25869. PubMed ID: 28718286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of FES as a Novel Radiosensitizing Target in Human Cancers.
    Kim BH; Kim YJ; Kim MH; Na YR; Jung D; Seok SH; Kim J; Kim HJ
    Clin Cancer Res; 2020 Jan; 26(1):265-273. PubMed ID: 31573955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter, phase III trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization.
    Muecke R; Micke O; Schomburg L; Glatzel M; Reichl B; Kisters K; Schaefer U; Huebner J; Eich HT; Fakhrian K; Adamietz IA; Buentzel J;
    Integr Cancer Ther; 2014 Nov; 13(6):463-7. PubMed ID: 25015649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.
    Bisht KS; Bradbury CM; Mattson D; Kaushal A; Sowers A; Markovina S; Ortiz KL; Sieck LK; Isaacs JS; Brechbiel MW; Mitchell JB; Neckers LM; Gius D
    Cancer Res; 2003 Dec; 63(24):8984-95. PubMed ID: 14695217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells.
    Rudolf E; Rudolf K; Cervinka M
    Cell Biol Toxicol; 2008 Apr; 24(2):123-41. PubMed ID: 17610029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing Core-Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy.
    Chang Y; He L; Li Z; Zeng L; Song Z; Li P; Chan L; You Y; Yu XF; Chu PK; Chen T
    ACS Nano; 2017 May; 11(5):4848-4858. PubMed ID: 28460158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, synergistically enhances radiation sensitivity in human cervical cancer cells.
    Woo SJ; Kim MJ; Kim RK; Yoon CH; Lim EJ; An S; Suh Y; Song JY; Kim IG; Cho CG; Lee SJ
    Anticancer Drugs; 2012 Jan; 23(1):43-50. PubMed ID: 21849886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dependence of the sister-chromatid exchange-inducing abilities of inorganic selenium compounds on the valence state of selenium.
    Ray JH; Altenburg LC
    Mutat Res; 1980 Jul; 78(3):261-6. PubMed ID: 7432361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization of cervical cancer cells to radiation by the cyclin-dependent kinase inhibitor dinaciclib.
    Zhang H; Chu T; Zheng J; Teng Y; Ma R; Zou L; Zhao H
    Med Oncol; 2022 Dec; 40(2):68. PubMed ID: 36586018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response.
    Zhang D; Dong Y; Zhao Y; Zhou C; Qian Y; Hegde ML; Wang H; Han S
    Oncol Rep; 2018 Nov; 40(5):2886-2895. PubMed ID: 30226618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in Linear Energy Transfer Affect Cell-killing and Radiosensitizing Effects of Spread-out Carbon-ion Beams.
    Shiba S; Wakatsuki M; Ohno T; Nakano T
    Anticancer Res; 2020 Oct; 40(10):5497-5502. PubMed ID: 32988872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.